Skip to main content
Clinical Trials/NCT06312904
NCT06312904
Completed
Not Applicable

Effects of Paravertebral Block on Postoperative Analgesia in Children Undergoing Lateral Incision Cardiac Surgery With Cardiopulmonary Bypass: a Randomized Controlled Trial

Chinese Academy of Medical Sciences, Fuwai Hospital1 site in 1 country100 target enrollmentMarch 11, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Postoperative Pain
Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
Enrollment
100
Locations
1
Primary Endpoint
opioid consumption during the first 24h after surgery
Status
Completed
Last Updated
last year

Overview

Brief Summary

This study aims to compare the effect of paravertebral block and local infiltration anesthesia on postoperative analgesia in children undergoing lateral incision cardiac surgery with cardiopulmonary bypass. The researchers hope to investigate whether children who undergo paravertebral block experience less postoperative pain, have fewer postoperative complications, and recover more quickly.

Registry
clinicaltrials.gov
Start Date
March 11, 2024
End Date
August 14, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
Responsible Party
Principal Investigator
Principal Investigator

Jingfei Guo

Attending Physician, Department of Anesthesiology

Chinese Academy of Medical Sciences, Fuwai Hospital

Eligibility Criteria

Inclusion Criteria

  • Children aged 6-14 years old;
  • Children who have atrial septal defect or ventricular septal defect scheduled for lateral incision cardiac surgery with cardiopulmonary bypass;
  • Inform consent signed by the parent or legal guardian.

Exclusion Criteria

  • Patients who were intubated, on mechanical circulatory support, or with intravenous inotropes before surgery;
  • Emergency surgery or redo cardiac surgery;
  • Body weight more than 50kg;
  • Diagnosed as severe pulmonary hypertension;
  • Left ventricular ejection fraction less than 45% in most recent echocardiography before surgery;
  • Allergic to ropivacaine or other regular anesthetics, analgesics or other medications regularly used in the study;
  • Preoperative platelet counts less than 100\*109/L, coagulopathy or bleeding tendency ;
  • Preoperatively using antiplatelets or anticoagulants;
  • Diagnosed with scoliosis or other contraindications for PVB.

Outcomes

Primary Outcomes

opioid consumption during the first 24h after surgery

Time Frame: 24 hours postoperatively

the total amount of sufentanil and other opioids will be calculated as morphine equivalent dose (MED) divided by body weight

Secondary Outcomes

  • The rate of opioid treatment for remedial analgesia between groups(24 hours postoperatively)
  • FPS-R scale recorded at 6, 12, 18 and 24h postoperatively(24 hours postoperatively)

Study Sites (1)

Loading locations...

Similar Trials